| Randall J Risinger, MD | |
|
277 Middle Tpke W, Manchester, CT 06040 | |
| (860) 432-4640 | |
| Not Available |
| Full Name | Randall J Risinger |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 25 Years |
| Location | 277 Middle Tpke W, Manchester, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013971316 | NPI | - | NPPES |
| 9002536 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 49814 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Francis Hospital & Medical Center | Hartford, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopedic Surgical Partners, P.c. | 1355394115 | 20 |
| Select Physical Therapy Of Connecticut Limited Partnership | 9638080625 | 11 |
News Archive
In its latest blow to obesity medication development efforts, the US Food and Drug Administration (FDA) yesterday notified Orexigen Therapeutics that it would need to conduct an extremely large-scale study of the long-term cardiovascular effects of its drug, Contrave, before approval could be considered.
Genzyme, a Sanofi company, today announced its support of International Rare Disease Day with a series of initiatives meant to call attention to rare diseases as an important public health issue and to improve rare disease education, research, and treatment.
All currently available drug-eluting stents are more effective than bare metal stents (BMS) for patients with diabetes, research suggests.
HHS Secretary Kathleen Sebelius and Secretary of Labor Hilda Solis Friday announced the release of $1 billion in stimulus funds to expand the use of electronic records and to train health care workers.
Researchers at the Hebrew University of Jerusalem have discovered that Vav1 - an oncogene (cancer-causing gene) found in recent years to be one of the factors in tumorous tissue growth - plays a wider role in several types of cancer than had previously been thought. The discovery has implications for further concentration on targeting this gene in cancer research.
› Verified 7 days ago
| Entity Name | Orthopedic Surgical Partners, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710017439 PECOS PAC ID: 1355394115 Enrollment ID: O20050222000478 |
News Archive
In its latest blow to obesity medication development efforts, the US Food and Drug Administration (FDA) yesterday notified Orexigen Therapeutics that it would need to conduct an extremely large-scale study of the long-term cardiovascular effects of its drug, Contrave, before approval could be considered.
Genzyme, a Sanofi company, today announced its support of International Rare Disease Day with a series of initiatives meant to call attention to rare diseases as an important public health issue and to improve rare disease education, research, and treatment.
All currently available drug-eluting stents are more effective than bare metal stents (BMS) for patients with diabetes, research suggests.
HHS Secretary Kathleen Sebelius and Secretary of Labor Hilda Solis Friday announced the release of $1 billion in stimulus funds to expand the use of electronic records and to train health care workers.
Researchers at the Hebrew University of Jerusalem have discovered that Vav1 - an oncogene (cancer-causing gene) found in recent years to be one of the factors in tumorous tissue growth - plays a wider role in several types of cancer than had previously been thought. The discovery has implications for further concentration on targeting this gene in cancer research.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Randall J Risinger, MD 1111 Cromwell Ave Ste 403, Rocky Hill, CT 06067-3454 Ph: (860) 525-4469 | Randall J Risinger, MD 277 Middle Tpke W, Manchester, CT 06040 Ph: (860) 432-4640 |
News Archive
In its latest blow to obesity medication development efforts, the US Food and Drug Administration (FDA) yesterday notified Orexigen Therapeutics that it would need to conduct an extremely large-scale study of the long-term cardiovascular effects of its drug, Contrave, before approval could be considered.
Genzyme, a Sanofi company, today announced its support of International Rare Disease Day with a series of initiatives meant to call attention to rare diseases as an important public health issue and to improve rare disease education, research, and treatment.
All currently available drug-eluting stents are more effective than bare metal stents (BMS) for patients with diabetes, research suggests.
HHS Secretary Kathleen Sebelius and Secretary of Labor Hilda Solis Friday announced the release of $1 billion in stimulus funds to expand the use of electronic records and to train health care workers.
Researchers at the Hebrew University of Jerusalem have discovered that Vav1 - an oncogene (cancer-causing gene) found in recent years to be one of the factors in tumorous tissue growth - plays a wider role in several types of cancer than had previously been thought. The discovery has implications for further concentration on targeting this gene in cancer research.
› Verified 7 days ago
Wells C Jacobson, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 36 Haynes St, Manchester, CT 06040 Phone: 860-646-0188 Fax: 860-645-9573 | |
Michael M Passaretti, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 36 Haynes St, Manchester, CT 06040 Phone: 860-646-0188 Fax: 860-645-9573 | |
Dr. Pedro A Romero, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 155 S Main St, Manchester, CT 06040 Phone: 860-647-1493 Fax: 860-643-6709 | |
James T Mazzara, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 29 Haynes St, Manchester, CT 06040 Phone: 860-649-2267 Fax: 860-288-2107 | |
Dr. Barry N. Messinger, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 9 Bruce Rd, Manchester, CT 06040 Phone: 860-670-3525 |